JP2000503633A - (11β,16β)―21―(3―カルボキシ―3―オキソプロポキシ)―11―ヒドロキシ―2’―メチル―5’H―プレグナ―1,4―ジエノ[17,16―D]オキサゾール―3,20―ジオンの製造 - Google Patents
(11β,16β)―21―(3―カルボキシ―3―オキソプロポキシ)―11―ヒドロキシ―2’―メチル―5’H―プレグナ―1,4―ジエノ[17,16―D]オキサゾール―3,20―ジオンの製造Info
- Publication number
- JP2000503633A JP2000503633A JP9521698A JP52169897A JP2000503633A JP 2000503633 A JP2000503633 A JP 2000503633A JP 9521698 A JP9521698 A JP 9521698A JP 52169897 A JP52169897 A JP 52169897A JP 2000503633 A JP2000503633 A JP 2000503633A
- Authority
- JP
- Japan
- Prior art keywords
- formula
- methyl
- compound
- dione
- dieno
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 11
- -1 3-carboxy-3-oxopropoxy Chemical group 0.000 title claims abstract description 10
- 150000001875 compounds Chemical class 0.000 claims abstract description 20
- 239000003054 catalyst Substances 0.000 claims abstract description 19
- FALRKNHUBBKYCC-UHFFFAOYSA-N 2-(chloromethyl)pyridine-3-carbonitrile Chemical compound ClCC1=NC=CC=C1C#N FALRKNHUBBKYCC-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000002904 solvent Substances 0.000 claims abstract description 13
- 229940014800 succinic anhydride Drugs 0.000 claims abstract description 13
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims abstract description 6
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims abstract description 3
- 238000000034 method Methods 0.000 claims description 29
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 27
- 238000006243 chemical reaction Methods 0.000 claims description 16
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical group CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 15
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims description 14
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 10
- 239000011260 aqueous acid Substances 0.000 claims description 5
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 5
- 239000011541 reaction mixture Substances 0.000 claims description 5
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 claims description 4
- HOPRXXXSABQWAV-UHFFFAOYSA-N anhydrous collidine Natural products CC1=CC=NC(C)=C1C HOPRXXXSABQWAV-UHFFFAOYSA-N 0.000 claims description 4
- UTBIMNXEDGNJFE-UHFFFAOYSA-N collidine Natural products CC1=CC=C(C)C(C)=N1 UTBIMNXEDGNJFE-UHFFFAOYSA-N 0.000 claims description 4
- GFYHSKONPJXCDE-UHFFFAOYSA-N sym-collidine Natural products CC1=CN=C(C)C(C)=C1 GFYHSKONPJXCDE-UHFFFAOYSA-N 0.000 claims description 4
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical group CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 claims description 4
- AVFZOVWCLRSYKC-UHFFFAOYSA-N 1-methylpyrrolidine Chemical compound CN1CCCC1 AVFZOVWCLRSYKC-UHFFFAOYSA-N 0.000 claims description 3
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 claims description 3
- AHVYPIQETPWLSZ-UHFFFAOYSA-N N-methyl-pyrrolidine Natural products CN1CC=CC1 AHVYPIQETPWLSZ-UHFFFAOYSA-N 0.000 claims description 3
- 239000007795 chemical reaction product Substances 0.000 claims description 3
- 150000007522 mineralic acids Chemical class 0.000 claims description 3
- ODKLEQPZOCJQMT-UHFFFAOYSA-N n,n-diethylpyridin-4-amine Chemical compound CCN(CC)C1=CC=NC=C1 ODKLEQPZOCJQMT-UHFFFAOYSA-N 0.000 claims description 3
- 239000012074 organic phase Substances 0.000 claims description 3
- KENSGCYKTRNIST-RVUAFKSESA-N 13649-57-5 Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]([C@@H](O)C[C@]23C)[C@@H]1[C@@H]3C[C@@H]1[C@@]2(C(=O)CO)N=C(C)O1 KENSGCYKTRNIST-RVUAFKSESA-N 0.000 claims description 2
- 238000001556 precipitation Methods 0.000 claims description 2
- 239000000047 product Substances 0.000 description 8
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 6
- 238000000855 fermentation Methods 0.000 description 6
- 230000004151 fermentation Effects 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 5
- 239000007810 chemical reaction solvent Substances 0.000 description 5
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- FBHSPRKOSMHSIF-GRMWVWQJSA-N deflazacort Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(C)=N[C@@]3(C(=O)COC(=O)C)[C@@]1(C)C[C@@H]2O FBHSPRKOSMHSIF-GRMWVWQJSA-N 0.000 description 4
- 229960001145 deflazacort Drugs 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 239000012467 final product Substances 0.000 description 4
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 2
- 125000005907 alkyl ester group Chemical group 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- TZIHFWKZFHZASV-UHFFFAOYSA-N methyl formate Chemical compound COC=O TZIHFWKZFHZASV-UHFFFAOYSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- IMSODMZESSGVBE-UHFFFAOYSA-N 2-Oxazoline Chemical compound C1CN=CO1 IMSODMZESSGVBE-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical group CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
- 241000430521 Alyssum Species 0.000 description 1
- 241000186063 Arthrobacter Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241000223208 Curvularia Species 0.000 description 1
- 241000223211 Curvularia lunata Species 0.000 description 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- RKHQGWMMUURILY-UHRZLXHJSA-N cortivazol Chemical compound C([C@H]1[C@@H]2C[C@H]([C@]([C@@]2(C)C[C@H](O)[C@@H]1[C@@]1(C)C2)(O)C(=O)COC(C)=O)C)=C(C)C1=CC1=C2C=NN1C1=CC=CC=C1 RKHQGWMMUURILY-UHRZLXHJSA-N 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 230000003314 glucocorticoidlike Effects 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- XRPITCBWOUOJTH-UHFFFAOYSA-N n,n-diethylpyridin-2-amine Chemical compound CCN(CC)C1=CC=CC=N1 XRPITCBWOUOJTH-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0036—Nitrogen-containing hetero ring
- C07J71/0057—Nitrogen and oxygen
- C07J71/0068—Nitrogen and oxygen at position 16(17)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Steroid Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.式II の化合物(11β,16β)−11,21−ジヒドロキシ−2’−メチル−5’ H−プレグナ−1,4−ジエノ[17,16−d]オキサゾール−3,20−ジ オンを、溶媒としての(C1−C4)カルボン酸の(C1−C4)アルキルエステル 中で塩基性触媒の存在下において、無水コハク酸と反応させることを含む式I の化合物(11β,16β)−21−(3−カルボキシ−3−オキソプ ロポキシ)−11−ヒドロキシ−2’−メチル−5’H−プレグナ−1,4−ジ エノ[17,16−d]オキサゾール−3,20−ジオンの製造法。 2.溶媒が酢酸エチルである請求の範囲第1項に記載の方法。 3.塩基性触媒がトリメチルアミン、トリエチルアミン、N−メチル−ピロリ ジン、ピリジン、4−(N,N−ジメチルアミノ)−ピリジン、4−(N,N− ジエチルアミノ)ピリジン、コリジン、ピコリンから選ばれる請求の範囲第1又 は2項に記載の方法。 4.塩基性触媒がトリエチルアミンである請求の範囲第1又は2項に記載の方 法。 5.反応温度が0℃〜60℃である請求の範囲第1項に記載の方法。 6.反応温度が15℃〜35℃である請求の範囲第1項に記載の方法。 7.式IIの化合物対無水コハク酸のモル比が1/2〜1/5である請求の範 囲第1項に記載の方法。 8.式IIの化合物対無水コハク酸のモル比が約1/2.5である請求の範囲 第1項に記載の方法。 9.塩基性触媒の量が式IIの化合物のモル量の0.1〜3倍である請求の範 囲第1項に記載の方法。 10.塩基性触媒の量が式IIの化合物のモル量と等モル量〜2倍である請求 の範囲第1項に記載の方法。 11.反応の完了後、約2.0〜3.5のpHにおいて酸水溶液を用いて反応 混合物を洗浄し、有機相を分離及び濾過し、そして好ましくは濾過された溶液を 小容積に濃縮した時の沈澱により式Iの最終生成物を回収することをさらに含む 請求の範囲第1〜9項のいずれか1つに記載 の方法。 12.酸水溶液が希無機酸の溶液である請求の範囲第10項に記載の方法。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP95119627.8 | 1995-12-13 | ||
| EP95119627 | 1995-12-13 | ||
| PCT/EP1996/005391 WO1997021723A1 (en) | 1995-12-13 | 1996-12-04 | PREPARATION OF (11β,16β)-21-(3-CARBOXY-3-OXOPROPOXY)-11-HYDROXY-2'-METHYL-5'H-PREGNA-1,4-DIENO[17,16-D]OXAZOLE-3,20-DIONE |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2000503633A true JP2000503633A (ja) | 2000-03-28 |
| JP4076097B2 JP4076097B2 (ja) | 2008-04-16 |
Family
ID=8219883
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP52169897A Expired - Lifetime JP4076097B2 (ja) | 1995-12-13 | 1996-12-04 | (11β,16β)―21―(3―カルボキシ―3―オキソプロポキシ)―11―ヒドロキシ―2’―メチル―5’H―プレグナ―1,4―ジエノ[17,16―D]オキサゾール―3,20―ジオンの製造 |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US6417350B1 (ja) |
| EP (1) | EP0879242B1 (ja) |
| JP (1) | JP4076097B2 (ja) |
| KR (1) | KR100433566B1 (ja) |
| CN (1) | CN100351266C (ja) |
| AT (1) | ATE192454T1 (ja) |
| AU (1) | AU707406B2 (ja) |
| CA (1) | CA2238692C (ja) |
| DE (1) | DE69608134T2 (ja) |
| EA (1) | EA000731B1 (ja) |
| ES (1) | ES2145507T3 (ja) |
| GR (1) | GR3033940T3 (ja) |
| HU (1) | HU226668B1 (ja) |
| MX (1) | MX9804574A (ja) |
| NO (1) | NO309094B1 (ja) |
| NZ (1) | NZ324299A (ja) |
| PT (1) | PT879242E (ja) |
| SI (1) | SI0879242T1 (ja) |
| WO (1) | WO1997021723A1 (ja) |
| ZA (1) | ZA9610413B (ja) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT876394E (pt) * | 1995-12-13 | 2001-08-30 | Lepetit Spa | Preparacao de (11beta,16beta)-21-(acetiloxi)-11-hidroxi-2'-metil-5'h-pregna-1,4-dieno¬17,16-d|-3,20-diona |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1141930B (it) * | 1980-04-28 | 1986-10-08 | Lepetit Spa | Esteri idrosolubili di steroido-ossazoli e loro composizioni farmaceutiche |
| GB8730216D0 (en) * | 1987-12-29 | 1988-02-03 | Lepetit Spa | Process for preparation of pregnenooxazolines |
| CN1092066A (zh) * | 1993-03-04 | 1994-09-14 | 商业部科学研究院 | 6-甲基-1,2,3-噁噻嗪-4(3h)-酮-2,2-二氧化物及其盐的合成方法 |
| PT876394E (pt) * | 1995-12-13 | 2001-08-30 | Lepetit Spa | Preparacao de (11beta,16beta)-21-(acetiloxi)-11-hidroxi-2'-metil-5'h-pregna-1,4-dieno¬17,16-d|-3,20-diona |
-
1996
- 1996-12-04 AT AT96942324T patent/ATE192454T1/de active
- 1996-12-04 CA CA002238692A patent/CA2238692C/en not_active Expired - Fee Related
- 1996-12-04 AU AU11757/97A patent/AU707406B2/en not_active Expired
- 1996-12-04 EP EP96942324A patent/EP0879242B1/en not_active Expired - Lifetime
- 1996-12-04 NZ NZ324299A patent/NZ324299A/en not_active IP Right Cessation
- 1996-12-04 CN CNB961990147A patent/CN100351266C/zh not_active Expired - Lifetime
- 1996-12-04 HU HU9903535A patent/HU226668B1/hu unknown
- 1996-12-04 JP JP52169897A patent/JP4076097B2/ja not_active Expired - Lifetime
- 1996-12-04 PT PT96942324T patent/PT879242E/pt unknown
- 1996-12-04 WO PCT/EP1996/005391 patent/WO1997021723A1/en not_active Ceased
- 1996-12-04 SI SI9630178T patent/SI0879242T1/xx unknown
- 1996-12-04 DE DE69608134T patent/DE69608134T2/de not_active Expired - Lifetime
- 1996-12-04 KR KR10-1998-0704319A patent/KR100433566B1/ko not_active Expired - Lifetime
- 1996-12-04 ES ES96942324T patent/ES2145507T3/es not_active Expired - Lifetime
- 1996-12-04 EA EA199800551A patent/EA000731B1/ru not_active IP Right Cessation
- 1996-12-11 ZA ZA9610413A patent/ZA9610413B/xx unknown
-
1998
- 1998-05-27 NO NO982413A patent/NO309094B1/no not_active IP Right Cessation
- 1998-06-08 MX MX9804574A patent/MX9804574A/es unknown
-
2000
- 2000-01-20 US US09/488,035 patent/US6417350B1/en not_active Expired - Lifetime
- 2000-07-12 GR GR20000401625T patent/GR3033940T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE192454T1 (de) | 2000-05-15 |
| HUP9903535A2 (hu) | 2000-03-28 |
| PT879242E (pt) | 2000-10-31 |
| WO1997021723A1 (en) | 1997-06-19 |
| ES2145507T3 (es) | 2000-07-01 |
| US6417350B1 (en) | 2002-07-09 |
| MX9804574A (es) | 1998-09-30 |
| NZ324299A (en) | 1999-04-29 |
| ZA9610413B (en) | 1997-09-09 |
| DE69608134T2 (de) | 2001-01-11 |
| NO982413L (no) | 1998-05-27 |
| CN1204340A (zh) | 1999-01-06 |
| NO982413D0 (no) | 1998-05-27 |
| NO309094B1 (no) | 2000-12-11 |
| CA2238692C (en) | 2004-07-20 |
| KR19990072025A (ko) | 1999-09-27 |
| AU707406B2 (en) | 1999-07-08 |
| DE69608134D1 (de) | 2000-06-08 |
| JP4076097B2 (ja) | 2008-04-16 |
| CA2238692A1 (en) | 1997-06-19 |
| EP0879242B1 (en) | 2000-05-03 |
| KR100433566B1 (ko) | 2004-07-16 |
| CN100351266C (zh) | 2007-11-28 |
| SI0879242T1 (en) | 2000-08-31 |
| GR3033940T3 (en) | 2000-11-30 |
| EA199800551A1 (ru) | 1998-12-24 |
| HUP9903535A3 (en) | 2000-04-28 |
| HU226668B1 (en) | 2009-06-29 |
| EP0879242A1 (en) | 1998-11-25 |
| HK1017690A1 (en) | 1999-11-26 |
| EA000731B1 (ru) | 2000-02-28 |
| AU1175797A (en) | 1997-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH0213680B2 (ja) | ||
| HU185184B (en) | Process for the preparation of 3beta,7beta,15-trihydroxy-5-and rosten-17-on and 3,15-dipivaletes thereof | |
| MXPA02010967A (es) | Proceso de oxidacion para preparar acido 6-alfa., 9.alfa.-difluoro-11.beta., 17.alfa.-dihidroxi-16.alfa.-metil-androst-1,4-dien-3-ona 17.beta.-carboxilico intermedio. | |
| JPH09509952A (ja) | 新規シリル化合物およびその使用 | |
| JP4095018B2 (ja) | フルメタゾンおよびその17−カルボキシルアンドロステン類似体の調製 | |
| JP2000503633A (ja) | (11β,16β)―21―(3―カルボキシ―3―オキソプロポキシ)―11―ヒドロキシ―2’―メチル―5’H―プレグナ―1,4―ジエノ[17,16―D]オキサゾール―3,20―ジオンの製造 | |
| CN100358914C (zh) | (11β,16β)-21-(乙酰氧基)-11-羟基-2’-甲基-5’H-孕甾-1,4-二烯并[17,16-d]唑-3,20-二酮 | |
| US4412953A (en) | Process for preparing 16α-hydroxy-17α-aminopregnane derivatives | |
| US3007949A (en) | Process for the preparation of substituted pregnane-diones | |
| HK1017690B (en) | Preparation of (11b, 16b)-21-(3-carboxy-3-oxopropoxy)-11-hydroxy-2'-methyl-5'h-pregna-1,4-dieno[17,16-d] oxazole-3,20-dione | |
| US3068223A (en) | Phosphate derivatives of steroids | |
| HK1017691B (en) | PREPARATION OF (11β,16β)-21-(ACETYLOXY)-11-HYDROXY-2'-METHYL-5'H-PREGNA-1,4-DIENO[17,16-D]OXAZOLE-3,20-DIONE | |
| HU204844B (en) | New process for producing corticosteroid-21-hemisuccinates | |
| HU204067B (en) | New process for producing steroid succinic acid esters | |
| KR19990085814A (ko) | 결정성 세피롬 황산염의 제조 방법 | |
| JPH0361679B2 (ja) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20061227 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20070410 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070717 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20070710 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20070705 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20071004 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20071127 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20080115 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20080125 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110208 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110208 Year of fee payment: 3 |
|
| R154 | Certificate of patent or utility model (reissue) |
Free format text: JAPANESE INTERMEDIATE CODE: R154 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120208 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120208 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130208 Year of fee payment: 5 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130208 Year of fee payment: 5 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140208 Year of fee payment: 6 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |